|8.12||-0.15 / -1.81%|
Data as of 4:01pm ET
|8.12||0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 9.83, with a high estimate of 9.83 and a low estimate of 9.83. The median estimate represents a +21.03% increase from the last price of 8.12.
The current consensus among 1 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.